World Health Organization. Accelerating action to stop obesity 2022. [Available from: 1]. Accessed date: November 2025 https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-to-stop-obesity
Ellulu MS, Patimah I, Khaza’ai H, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–63.
Article PubMed CAS Google Scholar
Lim Y, Boster J. Obesity and comorbid conditions [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK574535/
Mills DW, Woolley DM, Ammori BJ, et al. Changes in serum urate levels after bariatric surgery in patients with obesity: an observational study. Obes Surg. 2024;34(5):1737–41. https://doi.org/10.1007/s11695-024-07191-8.
Article PubMed PubMed Central Google Scholar
Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375-91.
Article PubMed CAS Google Scholar
Shi C, Zhu L, Chen X, et al. IL-6 and TNF-α induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J Interferon Cytokine Res. 2014;34(5):342–8.
Article PubMed PubMed Central CAS Google Scholar
Lyngdoh T, Marques-Vidal P, Paccaud F, et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based colaus study. Means T, editor. PLoS One. 2011;6(5):e19901.
Article PubMed PubMed Central CAS Google Scholar
Tang M, Li Y, Chen Z, et al. Association between visceral adiposity index and hyperuricemia and gout among US adults: a cross-sectional analysis of NHANES 2007–2018. Sci Rep. 2025;15:22196. https://doi.org/10.1038/s41598-025-08138-4.
Article PubMed PubMed Central Google Scholar
Bashyal S, Qu S, Karki M. Bariatric surgery and its metabolic echo effect on serum uric acid levels. Cureus. 2024. https://doi.org/10.7759/cureus.58103
Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. J Nephrol. 2017;30(1):1–10. https://doi.org/10.1007/s40620-017-0377-y.
Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta-analysis. PLoS One. 2016;11(10):e0163907. https://doi.org/10.1371/journal.pone.0163907.
Article PubMed PubMed Central CAS Google Scholar
Vafa L, Amini M, Kamran H, et al. The impact of obesity surgery on serum uric acid in people with severe obesity: a retrospective study. Clin Nutr Res. 2023;12(1):21–8.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. Accessed date: November 2025 For more information, visit: http://www.prisma-statement.org/https://doi.org/10.1136/bmj.n71
Newcastle-Ottawa quality assessment form for cohort studies [Internet]. Accessed date: November 2025 https://www.ncbi.nlm.nih.gov/books/NBK115843/bin/appe-fm3.pdf
Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17(2):176–84.
Chawla N, Kakar A, Khetan M, Mittal T. Does weight loss due to bariatric surgery affect serum uric acid levels? Curr Med Res Pract. 2015;5(5):204–8.
Choromańska B, Myśliwiec P, Łuba M, et al. Impact of weight loss on the total antioxidant/oxidant potential in patients with morbid obesity—a longitudinal study. Antioxidants. 2020;9(5):376–6.
Article PubMed PubMed Central Google Scholar
Davoudi Z, Shokuhi Sabet A, Toreyhi H, et al. Impact of sleeve gastrectomy on uric acid levels in patients with obesity: a comparative study. Obes Surg. 2024;34(7):2704–10.
Dilimulati D, Du L, Huang X, et al. Serum fibrinogen-like protein 1 levels in obese patients before and after laparoscopic sleeve gastrectomy: a six-month longitudinal study. Diabetes Metab Syndr Obes: Targets Ther. 2022;15:2511–20.
Elhag W, El Ansari W. Durability of Cardiometabolic outcomes among adolescents after sleeve gastrectomy: first study with 9-year follow-up. Obes Surg. 2021. https://doi.org/10.1007/s11695-021-05273-4
Hu L, Wang L, Li S, et al. Evaluation study of single-anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of Chinese obese patients based on efficacy and nutrition. Sci Rep. 2024;14(1). https://doi.org/10.1038/s41598-024-63235-5
Li YX, Fang DH, Liu TX. Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2. Med. 2018;97(31):e11537.
Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after roux-en-Y gastric bypass surgery. Surgery. 2011;149(5):654–61.
Article PubMed PubMed Central Google Scholar
Li M, Liu Y, Zeng N, et al. Alterations in the serum urate concentrations after bariatric surgery: a short-term prospective observational study. Obes Surg. 2021;31(4):1688–95.
Liu W, Zhang H, Han X, et al. Uric acid level changes after bariatric surgery in obese subjects with type 2 diabetes mellitus. Ann Transl Med. 2019;7(14):332–42.
Article PubMed PubMed Central CAS Google Scholar
Maglio C, Peltonen M, Neovius M, et al. Effects of bariatric surgery on gout incidence in the Swedish obese subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2016;76(4):688–93.
Article PubMed PubMed Central Google Scholar
Malapan K, Goel R, Tai CM, et al. Laparoscopic Roux-en-Y gastric bypass for nonobese type II diabetes mellitus in Asian patients. Surg Obes Relat Dis. 2014;10(5):834–40.
Menenakos E, Doulami G, Tzanetakou IP, et al. The use of serum uric acid concentration as an indicator of laparoscopic sleeve gastrectomy success. Int Surg. 2015;100(1):173–9.
Article PubMed PubMed Central Google Scholar
Serpa Neto A, Rossi FM, Guedes L, et al. Relation of uric acid with components of metabolic syndrome before and after Roux-en-Y gastric bypass in morbidly obese subjects. Arq Bras Endocrinol Metabologia. 2011;55(1):38–45.
Richette P, Poitou C, Manivet P, et al. Weight loss, xanthine oxidase, and serum urate levels: a prospective longitudinal study of obese patients. Arthritis Care Res. 2016;68(7):1036–42.
Romero-Talamás H, Daigle CR, Aminian A, et al. The effect of bariatric surgery on gout: a comparative study. Surg Obes Relat Dis. 2014;10(6):1161–5.
Sarzynski MA, Jacobson P, Rankinen T, et al. Changes in uric acid levels following bariatric surgery are not associated with SLC2A9 variants in the Swedish obese subjects study. Kloss-Brandstaetter A, editor. PLoS One. 2012;7(12):e51658.
Article PubMed PubMed Central CAS Google Scholar
Shen Y, Zhang B, Hu X, et al. Metabolic surgery results in greater metabolic benefits in patients who achieve healthy weight. Surg Obes Relat Dis. 2024;20(10):925–34.
Sierżantowicz R, Lewko J, Trochimowicz L, et al. Effectiveness of bariatric procedures based on selected laboratory parameters of patients from rural areas in polish population. Adv Clin Exp Med. 2017;26(4):679–86.
Silvestre V, Ruano M, Domínguez Y, et al. Morbid obesity and gastric bypass surgery: biochemical profile. Obes Surg. 2004;14(9):1227–32.
Article PubMed CAS Google Scholar
Song K, He M, Kong X, et al. Benefits of uric acid-lowering medication after bariatric surgery in patients with gout. BMC Surg. 2024;24(1):186.
Article PubMed PubMed Central CAS Google Scholar
Toolabi K, Arefanian S, Golzarand M, et al. Effects of laparoscopic Roux-en-Y gastric bypass (LRYGB) on weight loss and biomarker parameters in morbidly obese patients: a 12-month follow-up. Obes Surg. 2011;21(12):1834–42.
Comments (0)